<DOC>
	<DOCNO>NCT01904162</DOCNO>
	<brief_summary>Previous clinical study indicate finafloxacin well-tolerated treatment-related adverse event . As part clinical development finafloxacin , PK study require determine effect variable PK profile finafloxacin . This study aim determine effect age gender pharmacokinetic profile finafloxacin .</brief_summary>
	<brief_title>Effect Age Gender PK Tolerability Finafloxacin</brief_title>
	<detailed_description />
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Healthy adult male and/or female , 18 35 year age ( inclusive ) , 65 year ( ≥ 65 year ) . Body mass index ( BMI ) ≥ 18 ≤ 30 kg/m2 . No clinically significant abnormal finding , judge Principal Investigator ( PI ) , physical examination , ECG , medical history , clinical laboratory result screen . Negative screen human immunodeficiency virus ( HIV ) , hepatitis B , C and/or positive hepatitis B surface antigen ( HBsAg ) , antiHepatitis C virus ( HCV ) antibody . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior first dose throughout study use one follow acceptable birth control method : 1 . Surgically sterile ( bilateral tubal ligation , hysterectomy , bilateral oophorectomy ) minimum 6 month . 2 . Intrauterine device ( IUD ) place least 3 month . 3 . Barrier method ( condom diaphragm ) plus spermicide least 14 day prior first dose throughout study . 4 . Surgical sterilization partner ( vasectomy 6 month minimum ) . 5 . Hormonal contraceptive least 3 month prior first dose study throughout study . Females nonchildbearing potential either postmenopausal least 2 consecutive year prior Day 1 , folliclestimulating hormone ( FSH ) level &gt; 40 IU/mL undergone one follow sterilization procedure least 6 month prior Day 1 : 1 . Bilateral tubal ligation . 2 . Hysterectomy . 3 . Hysterectomy unilateral bilateral oophorectomy . 4 . Bilateral oophorectomy . Male subject either sexually inactive ( abstinent ) use barrier method 14 day prior first dose throughout study . In addition , male subject female subject childbearing potential advise remain sexually inactive keep birth control method least 30 day case females 90 day case male , follow last dose . Male subject additionally advise donate sperm 90 day follow last dose . Was able understand willing sign ICF . Subject psychiatric , neurological , behavioral disorder may interfere conduct interpretation study . Subject history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological disorder capable significantly alter absorption , metabolism , elimination drug , consider risk study medication could interfere interpretation data . Subject abnormality 12lead ECG , opinion PI , increase risk associate participate study . Subject clinically relevant abnormal laboratory data vital sign screen , abnormal laboratory value , opinion PI , could interfere assessment safety . Subject exposure investigational drug within 30 day prior screen . Subject know hypersensitivity contraindication use fluoroquinolones . Subject history tendon rupture tendonitis . Subject receive corticosteroid therapy 4 week prior study drug administration . Subject prior participation finafloxacin investigational study . Subject current diagnosis know history drug and/or alcohol abuse . Subject smoke &gt; 10 cigarette per day unable unwilling refrain nicotine study confinement . Subject receive drug know strongly inhibit induce enzyme within cytochrome P450 ( CYP ) system within 30 day prior first dose . Subject exposure medication ( exception hormone replacement therapy [ HRT ] elderly subject ) , include overthecounter ( OTC ) medication , 7 day prior dose . Subject exposure antacid medication 24 hour prior study drug administration collection last PK sample . Subject consume grapefruit 10 day prior study drug administration collection last PK sample . Subject clinically significant illness 3 month study . Subject donate blood plasma previous 56 day prior dose . Subject unlikely comply clinical study protocol . Subject member clinical site Sponsor personnel immediate family , define spouse , parent , sibling , child , grandparent , grandchild . Any condition , opinion PI , preclude participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>